4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-20-020091
CIK 0001260990other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:49 PM ET
Size
5.4 KB
Accession
0001209191-20-020091
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-03-17−14,260→ 14,260 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (14,260 underlying)
Footnotes (1)
- [F1]Fully vested on grant date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:49 PM ET
- Size
- 5.4 KB